Navigation Links
Cell Therapeutics, Inc. Announces Filing of Form 10-K
Date:3/28/2008

SEATTLE, March 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced that the filing of its annual report on Form 10-K for the year ended December 31, 2007 has now been timely completed. This filing is available for review on CTI's Web site at http://www.CellTherapeutics.com or on the Securities and Exchange Commission's Web site at http://www.sec.gov.

As required under Nasdaq Marketplace Rule 4350(b)(1)(B), CTI also announced that its independent auditor's report included in the annual report on Form 10-K contains a "going concern" qualification.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.CellTherapeutics.com.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

E: media@ctiseattle.com

http://www.CellTherapeutics.com/media.htm

Investors Contact:

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.CellTherapeutics.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award
2. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
3. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
4. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
5. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
6. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
7. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
8. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
9. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
10. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
11. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...swire-FirstCall/ -- Biodel Inc. (Nasdaq:,BIOD) tod...er ended March,31, 2008. The net loss for the quar...ain on track in our development of VIAject(TM)," s...del. "The last patient visits for,both pivotal Pha...uly. We,expect to announce top line data late in t...
(Date:5/9/2008)...Newswire/ -- Dr. Michael W. Long recently,was name...ator of the Year.,The "Leader & Innovator" award r...e state of Michigan who have demonstrated or creat...te a better quality of life in our,communities. No... Lawrence,Technological University for their prove...
(Date:5/9/2008)... OXFORD, England, May 9 /-,EUSA Pharm...utical company,focused on oncology, pain control a...leted its acquisition of Cytogen Corporation, foll...special meeting on 8 May., Under the terms of the...receive $0.62 per share, valuing the company at $2...
(Date:5/9/2008)... Mass., May 9 /-,Takeda Pha... and Millennium,Pharmaceuticals, Inc., "Millennium...completion of Takeda,s cash tender offer by its wh... to acquire all outstanding shares,of Millennium c...offering period for the tender offer expired at 12...
Breaking Biology Technology:Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 2Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 3Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 4Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 5Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 6Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 7Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 8Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results 9President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year 2President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year 3EUSA Pharma Completes Acquisition Of Cytogen Corporation 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 2Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 3Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 4Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period 5
...heaton Franciscan System and GE Medical Systems re...at extends their collaboration in the medical fiel... care and housing service provider, will receive a...s; a portfolio of consulting, education and develo...in addition to the purchase of imaging and monitor...
... Foundry, Inc. announced Friday that its flagship ...ulting rAVe Best of 2003 Award . The Madison-base... and has recently added new customers that include...company recently established new reseller partner ...ics to provide marketing and training services. ...
...ukesha school district is launching an online dist...k of virtual high schools called iQ Academies. , .... DPI will pay tuition on enrollments through Feb.... teaming up with KC Distance learning (KCDL), a Po...for high school students. The school is chartered ...
...s the inaugural column of a new feature on WTN cal...eriences and insights provided by the team at Cohe... approach about the alignment of business process ... such change management, business process automati... business through the lens of IT technologies and ...
Other Biology Technology:Waukesha to Offer Virtual High School 2
(Date:5/8/2008)...ow that the genome (DNA) of humans and many other ...ing their attention to discovering how the many th...ker bees of living cells that can turn genes on an...velop new techniques and tools. Scientists in the ...etic Field Laboratory at Florida State University,...
(Date:5/8/2008)...ust plagues have been viewed as one of the most sp...us fashion, as many as 10 billion critters can sud... destructive paths that bring starvation and econo... scientists led by Iain Couzin of Princeton Univer... Oxford and the University of Sydney believes it m...
(Date:5/8/2008)...SU researchers received grants totaling more than ...e Advancement of Science and Technology under its ...RS program backs projects with the potential for p...ing to the OCAST Web site. Funding is awarded to ...rganizations to accelerate the development of tech...
(Date:5/7/2008)... N.Y. How many genes are in the human genome" W...seases" How many mobile elements, simple sequence...nome" What are the largest genes and proteins" H...east, or bacteria" , A new handbook, A Short ...r commonly asked questions. Written in questionan...
Breaking Biology News(10 mins):Magnet Lab researchers make observing cell functions easier 2What's bugging locusts? 2OCAST funds OSU projects with commercial viability 2Elbit Imaging Ltd Selected for Listing on Nasdaq Global Select Market 8529 1Elbit Imaging Ltd Selected for Listing on Nasdaq Global Select Market 8529 2Elbit Imaging Ltd Selected for Listing on Nasdaq Global Select Market 8529 3AHIP Releases Individual Market Guarantee Access Proposal Announces Support for Third Party Review of Rescission Decisions 8526 1AHIP Releases Individual Market Guarantee Access Proposal Announces Support for Third Party Review of Rescission Decisions 8526 2AHIP Releases Individual Market Guarantee Access Proposal Announces Support for Third Party Review of Rescission Decisions 8526 3AHIP Releases Individual Market Guarantee Access Proposal Announces Support for Third Party Review of Rescission Decisions 8526 4DermTech Is Issued U S Patent for the Early Detection Staging and Monitoring of Melanoma 2294 1DermTech Is Issued U S Patent for the Early Detection Staging and Monitoring of Melanoma 2294 2USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES 2291 1USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES 2291 2
...tephen Goff and colleagues have identified a novel... mediate a potent resistance to murine leukemia vi...chers found that the high level of FEZ1 expression...ignificant block to retroviral infection ?retrovir...ize the viral DNA, but were excluded from entering...
...ts of the latest full range survey indicate that t...e coordinators of a 2005 winter effort to count th...ervation Society. After a massive winter endeavor ...in the Russian Far East, the last stronghold of Si...ly 334-417 adult tigers remain in the region, alon...
... muscle tissue from tarantulas, an HHMI internatio...ed out the detailed structure and arrangement of t...t. Their work, which takes advantage of a new tech...te, provides new insights into the molecular basis...too. , "We have solved the structure of the array...
...rch conducted in monkeys at the Oregon National Pr... University, suggests high doses of vitamin C may ... of smoking in unborn babies. The research may ben...nue to smoke throughout pregnancy despite physicia...nt edition of the American Journal of Respiratory ...
Other Biology News:Siberian tigers hang tough 2Siberian tigers hang tough 3Spiders help scientists discover how muscles relax 2Spiders help scientists discover how muscles relax 3OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 3
...olamine-Binding Protein (PEBP) does not share sign...tors. PEBP is expressed in the central nervous sy... One important role PEBP is involved in is exertin...ases including thrombin, neuropsin, and chymotryps...
TriContinentMultiWash III from Femto Scientific
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25.
Request Info
Biology Products: